Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19364562.
- Also identified by DOI 10.1016/j.jpeds.2008.11.031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recently, intrauterine transfusions and hematopoietic cell transplantation (HCT) have changed homozygous alpha-thalassemia from a frequently fatal disease to a potentially survivable condition. We present a patient with Hemoglobin Bart's disease who was cured after failing to engraft with 1 unrelated HCT, but engrafting after a second unrelated donor HCT.
Medical subject headings
- Blood Transfusion, Intrauterine
- Fetal Diseases
- Hematopoietic Stem Cell Transplantation
- Hemoglobins, Abnormal
- alpha-Thalassemia